Generics

Biosimilar drugs saved $7.9 billion dollars in 2020 alone, more than tripling the $2.5 billion saved in 2019, according to the latest report from the Association for Accessible Medicines.

Hikma will be responsible for commercializing Bilastine once it is FDA approved.

Durezol had a market value of approximately $106 million for the 12-month period ended June 2021, according to IQVIA.

The goal of the pilot program is to allow American and European assessors the ability to concurrently exchange their views with applicants on scientific issues during the development phase of complex generic/hybrid products.

Rani has agreed to evaluate BFI-751 in its RaniPill capsule, a novel, proprietary and patented platform technology intended to replace subcutaneous or IV injection of biologics with oral dosing.

The drug, which had already been approved by the Food and Drug Administration, is indicated to treat acute promyelocytic leukemia. 

Brexpiprazole is an atypical antipsychotic indicated for use as adjunctive therapy to antidepressants for the treatment of major depressive disorder and schizophrenia.

Alembic's generic Anafranil capsules provide a treatment for obsessions and compulsions in patients with OCD.